Heron Therapeutics (0J4V.LSE) Q2 2024 Earnings

7MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.15
-0.11
-0.06
-0.02

Details

Expected EPS
-0.074525
Actual EPS
-0.02
Surprise EPS
0.05
Surprise Percent
+73.16%

Description

Heron Therapeutics (0J4V.LSE) has reported earnings of -0.02 per share for Q2 2024.

0 Comments

Share your thoughts